跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AS-15
首页
药物
AS-15
AS-15
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
IL-15 mutant polypeptides as IL-15 antagonists and encoding nucleic acids
申请人: INST NAT SANTE RECH MED
优先权: 2013
US
2 件公开
15-fluoro prostaglandins as acular hypotensives
申请人: KLIMKO PETER G
优先权: 2002
US
2 件公开
GDF-15 as a haematological toxicity biomarker
申请人: NOVARTIS AG
优先权: 2016
US
1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
申请人: WARNER LAMBERT CO
优先权: 2003
US
2 件公开
Growth differentiation factor 15 as biomarker for metformin
申请人: SANOFI AVENTIS DEUTSCHLAND
优先权: 2015
EP
US
WO
10 件公开
GDF-15 AS BIOMARKER IN TYPE 1 DIABETES
申请人: HESS GEORG
优先权: 2008
US
PK-15 cell line capable of stably expressing porcine Mx2 protein as well as preparation and application of PK-15 cell line
申请人: LANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES CHINA CENTER FOR ANIMAL HE
优先权: 2025
CN
15-membered clarithromycin derivative as well as preparation method and application thereof
申请人: UNIV SHANDONG
优先权: 2021
CN
药物
反馈